Answers are grounded in this paper and cite their sources.
Benzothiazinones (BTZs) form a new class of potent antimycobacterial agents. Although the target of BTZs has been identified as decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1), their detailed mechanism of action remains obscure. Here we demonstrate that BTZs are activated in the bacterium by reduction of an essential nitro group to a nitroso derivative, which then specifically reacts with a cysteine residue in the active site of DprE1.
No takes yet. Share an insight, caveat, or question.
Jessen‐Trefzer et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: